The preventive effect of bisphosphonate to urolithiasis
Not Applicable
Recruiting
- Conditions
- urolithiasis
- Registration Number
- JPRN-UMIN000002979
- Lead Sponsor
- Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients' stone include no calcium. Patients with treatment for osteoporosis (vitamine D or elcitonin). Patiens who were administrated bisphosphonate between the past three years. Patients with stricture of the esophagus or gullet achalasia. Patients cannot keep a standing position or seat digit at the time of taking more than 30 minutes. A pregnant woman or the case of the woman with possibility becoming pregnant. Patients that takes hormone replacement therapy. Patients that takes an adrenocorticosteroid drug. Patients that takes a citric acid drug. Patients that takes the anti-malignant tumor agent. Patients that it is judged that medication is not appropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence of urolithiasis
- Secondary Outcome Measures
Name Time Method Risk-parameter of urolithiasis